Skip to content
akaturk Academic measurement
  1. Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  2. Yan Dal Moleküler Biyoloji ve Genetik
Articles 24 YÖKSİS 24 · OpenAlex 0 Total citations 492 h-index 13 · OpenAlex OpenAlex coverage %100 matched 24 / 24 Q1 articles 14 Scopus · WoS Q1 6 Best field rank #79 / 385 Keyword · top 20.5% Co-authors 114 5 Turkish institutions

Citation impact

Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.

OpenAlex YÖKSİS articles matched in OpenAlex: 24 + YÖKSİS · co-author record: 3
h-index 13 Percentile in Türkiye: 89 #283 of 2,152 at their university by h-index
i10-index
15
Total citations
492
Top 13% in Türkiye
Per article
18.2
FWCI
1.90
1.00 = world average
World top 1%
1
World top 10%
4
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 3 articles (44 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Citing publications Crossref 90 publications citing 24 DOI-bearing articles · 3 Türkiye-affiliated

Field ranking

Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.

Works 24

YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.

Indexes and citation percentiles

?
TR Index 3 articles
OpenAlex citation percentile
Top 1%1
Top 10%3
Avg · n 24 %72.0
Other counts

Scopus (SJR)

  • YÖKSİS rows 19

WoS (JCR)

  • YÖKSİS rows 17

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

24articles

Journals with publications

15 journals

Narrow down

Scopus (SJR)
Q114 Q22 Q33 Q40
WoS (JCR)
TR Index

Article list

  1. 2025 Deglycosylation of VEGF Produced in Pichia pastoris Reduces its in Vitro Binding and Angiogenic Effect. Biotechnology journal DOI 10.1002/biot.70153 YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.5%
  2. 2025 Cell line development and bioreactor process optimization for an atezolizumab biosimilar. Biotechnology and applied biochemistry DOI 10.1002/bab.2704 YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.4%
  3. 2025 Novel anti-VEGF scFv antibodies with superior in vitro and in vivo activities. Scientific reports DOI 10.1038/s41598-025-11406-y YÖKSİS OpenAlex 71.6%
  4. 2025 Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish. The FEBS journal DOI 10.1111/febs.17337 YÖKSİS SJR Q1 JCR Q2 OpenAlex 79.0%
  5. 2025 Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris. Microbial biotechnology DOI 10.1111/1751-7915.70077 YÖKSİS OpenAlex 58.6%
  6. 2024 Biomarkers of NRF2 signalling: Current status and future challenges. Redox biology DOI 10.1016/j.redox.2024.103134 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%
  7. 2023 Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability. Biochimica et biophysica acta. Proteins and proteomics DOI 10.1016/j.bbapap.2023.140915 YÖKSİS SJR Q1 JCR Q3 OpenAlex 63.7%
  8. 2023 Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris. Scientific reports DOI 10.1038/s41598-023-32021-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.0%
  9. 2023 Omicron variants bind to human angiotensin-converting enzyme 2 (ACE2) much stronger due to higher number of charged-charged interactions Biotech Studies DOI 10.38042/biotechstudies.1332403 YÖKSİS TR Index SJR Q3 OpenAlex 47.5%
  10. 2023 Fluorescence-based thermal stability screening is concentration-dependent and varies with protein size Frontiers in Life Sciences and Related Technologies (Online) DOI https://dergipark.org.tr/tr/download/article-file/2792907 YÖKSİS TR Index OpenAlex 47.7%
  11. 2022 Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv. Scientific reports DOI 10.1038/s41598-022-09324-4 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 91.7%
  12. 2021 Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations BIOTECHNOLOGY AND BIOENGINEERING DOI 10.1002/bit.27610 YÖKSİS SJR Q1 JCR Q2 OpenAlex 56.5%
  13. 2021 CENP-A Nucleosome is a Sensitive Allosteric Scaffold for DNA and Chromatin Factors. Journal of molecular biology DOI 10.1016/j.jmb.2020.166789 YÖKSİS SJR Q1 JCR Q1 OpenAlex 56.4%
  14. 2021 Roles of matrix metalloproteinases in the cornea: A special focus on macular corneal dystrophy Medicine in Drug Discovery DOI 10.1016/j.medidd.2021.100095 YÖKSİS SJR Q3 OpenAlex 69.5%
  15. 2020 Conformational changes in a Vernier zone region: Implications for antibody dual specificity PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS DOI 10.1002/prot.25964 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.4%
  16. 2019 Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS DOI 10.1002/prot.25685 YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.1%
  17. 2019 Protein engineering approaches for antibody fragments: directed evolution and rational design approaches. Turkish journal of biology = Turk biyoloji dergisi DOI 10.3906/biy-1809-28 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 87.9%
  18. 2019 Sensitive detection of glucagon aggregation using amyloid fibril-specific antibodies. Biotechnology and bioengineering DOI 10.1002/bit.26994 YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.5%
  19. 2018 Both positional and chemical variables control in vitro proteolytic cleavage of a presenilin ortholog JOURNAL OF BIOLOGICAL CHEMISTRY DOI 10.1074/jbc.RA117.001436 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.2%
  20. 2016 Enzymatic hydrolysis by transition-metal-dependent nucleophilic aromatic substitution NATURE CHEMICAL BIOLOGY DOI 10.1038/nchembio.2191 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 90.6%

Projects 5

  1. 2021 Rekombinant İnsan Serum Albümin Varyantlarının Bilirubin Taşıma Potansiyelinin Belirlenmesi ve Hiperbilirubinemide Terapötik Potansiyelinin in vivo Zebrabalığı Modelinde Araştırılması -Tübitak 1002 · Tamamlandı 2021-04-15 – 2022-04-15
  2. 2019 Maküler Kornea Distrofisi İçin Yeni Bir Topikal Tedavi Yönteminin Geliştirilmesi -Tübitak 1003 · Tamamlandı 2019-11-15 – 2022-05-15
  3. 2019 Tıbbi Patoloji Alanında Sıklıkla Kullanılan Akciğer Karsinomu Monoklonal Antikorlarının Geliştirilmesi Ve Üretilmesi -Tübitak 1003 · Tamamlandı 2019-12-01 – 2023-09-01
  4. 2020 Ülkemizde ve Dünyada Halk Sağlığını En Fazla Tehdit Eden HIV, HPV ve Influenza Kaynaklı Enfeksiyonlara Karşı Tanı Kitleri, İlaç Formülasyonları ve Aşı Geliştirilmesi -Tübitak 1004 · Tamamlandı 2020-03-28 – 2023-09-28
  5. 2019 Kanser Tedavisi İçin VEGF'e Bağlanan Yeni Nesil Rekombinant Antikor Parçacıklarının Geliştirilmesi -Tübitak 3501 · Tamamlandı 2019-10-15 – 2022-06-15

Books 6 See all (6) →

  1. 2025 Advances in Protein Chemistry and Structural Biology Academic Press ISBN 1876-1623 Kitap Bölümü · Bilimsel Kitap
  2. 2025 Advances in Protein Chemistry and Structural Biology Academic Press ISBN 1876-1623 Kitap Bölümü · Bilimsel Kitap
  3. 2021 Protein Yapısı, Mühendisliği, Etkileşimleri Ankara Nobel Tıp Kitabevleri ISBN 9786257564038 Kitap Bölümü · Bilimsel Kitap
  4. 2021 Protein Yapısı, Mühendisliği, Etkileşimleri Ankara Nobel Tıp Kitabevleri ISBN 9786257564038 Kitap Bölümü · Bilimsel Kitap
  5. 2020 Advances in Protein Chemistry and Structural Biology Academic Press Inc. ISBN 1876-1631 Kitap Bölümü · Bilimsel Kitap

Proceedings 7 See all (7) →

  1. — Peptide linker characteristics of an anti-VEGF scFv antibody affects both its biophysical properties and efficacy in cancer 2nd International Cancer & Ion Channels Congress
  2. — Antibody Engineering Approaches on Vernier Zone Residues to Develop Biobetter Antibody Therapeutics for Cancer Treatment 2nd International Cancer & Ion Channels Congress
  3. — Nanobodies as new therapeutics in cancer treatment: Camelization of an anti-VEGF nanobody through antibody engineering approaches 2nd International Cancer & Ion Channels Congress
  4. 2019 Importance Of Vernier Zone Residues In Antibody Engineering Approaches 11th PEGS Europe Summit (2019)
  5. — Development of SIMOA-based kit to determine NRF2 level 5TH SCIENTIFIC MEETING OF COST ACTION CA20121

← Back to academicians

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
114
With an akaturk profile
14
Turkish institutions
5
Co-authored works
%92

Academic co-authors 14

  1. GÜLÇİN ÇAKAN AKDOĞAN Doktor Öğretim Üyesi · Dokuz Eylül Üniversitesi same university 5
  2. MEHMET İNAN Profesör · Dokuz Eylül Üniversitesi same university 5
  3. MEHMET ENDER AVCI Öğretim Görevlisi (uygulamalı Birim) · Dokuz Eylül Üniversitesi same university 3
  4. CANAN ASLI YILDIRIM Profesör · Dokuz Eylül Üniversitesi same university 2
  5. SEYİT KALE Doktor Öğretim Üyesi · İzmir Katip Çelebi Üniversitesi 2
  6. ATTİLA GÜRSOY Profesör · Koç Üniversitesi 1
  7. AYKUT ÖZKUL Profesör · Ankara Üniversitesi 1
  8. BİLGİ GÜNGÖR Doktor Öğretim Üyesi · Dokuz Eylül Üniversitesi same university 1
  9. GÜLGÜN OKTAY Profesör · Dokuz Eylül Üniversitesi same university 1
  10. MEHMET ÖZTÜRK Profesör · İzmir Tınaztepe Üniversitesi 1
Show all (14)
  1. ZEHRA ÖZLEM KESKİN ÖZKAYA Profesör · Koç Üniversitesi 1
  2. ŞABAN TEKİN Profesör · Sağlık Bilimleri Üniversitesi 1
  3. ŞENİZ İNANÇ SÜRER Doktor Öğretim Üyesi · İzmir Tınaztepe Üniversitesi 1
  4. ŞERİF ŞENTÜRK Profesör · Dokuz Eylül Üniversitesi same university 1

National collaboration 5 institutions

Within own university8 joint works · Dokuz Eylül Üniversitesi

  1. İzmir Katip Çelebi Üniversitesi 2 works · 1 academics
  2. İzmir Tınaztepe Üniversitesi 2 works · 2 academics
  3. Ankara Üniversitesi 1 works · 1 academics
  4. Koç Üniversitesi 1 works · 2 academics
  5. Sağlık Bilimleri Üniversitesi 1 works · 1 academics

Other co-authors (incl. international) 100

MERVE ARSLAN 8Raquel Lieberman 5Olcay Mert 4Ayca Zeybek Kuyucu 3David Heaner Jr 3Dilara Karadağ 3Dogu Sayili 3Jennifer Johnson 3Ridvan Orkut 3Seyda Gullu 3Alec Desai 2Arne Staby 2Aslı Kurden Pekmezci 2Aysegul Demirtas 2Busra Lulaci 2Ceren Ozer 2Ceren Ulker 2Désirée Asgreen 2Ebru Onal 2Hakan Soyturk 2Huseyin Akinturk 2Idil Tilmensagir 2Ivan Morales 2Jennifer Maynard 2Jeongmin Hyun 2Jesper Mogensen 2Kevin Entzminger 2Lotte Spang 2Matthew Torres 2Murat Karadağ 2Ozlem Erez 2Peter Tessier 2Samuel Stimple 2Stefan Dimitrov 2Swe-Htet Naing 2Tuğçe Uluçay 2brahim Oguzhan Tarman 2Alex JonkeAli Mert SencerAly Sheppard

Show all (100)

Arzu Tas EkizAvni JainAybike ErdoganCasey BethelCeren Ozer CokgezmeChiamaka UkachukwuCumhur AdiayDavid SmalleyDeniz DoğanEge TekinElif YavşanEmily MakowskiEmine GelinciErhan BalErhan CitakEsra Ersoz GulsevenFahriye SaracGERHARD WINGENDERGizem AralanGizem ArikGizem Yilmazer AltunHakan EnulHasan Onur CaglarHelin OzaktasHivda Ulbegi PolatHyojung KimIbrahim Oguzhan TarmanIrem AbaciJames GumbartJan AmstrupJason DruryJennifer PaiJim SpainJosh GeorgeKaren DuusKrishna VukotiMehmet Can UcarMelda Guray TaskinardaMerve BasolMuge OzkanMuzaffer YildirimNazlı Eda KaleliOzge AksoyRyan OliverSaniye Gül KayaSemiramis YılmazSerdar UzarShannon HillSrinivas ChakravarthyThomas TruskettTugce Canavar YildirimUmur KelesUmut HaskokVolker UrbanWenjia LouXingjian TaoYavuz MercanYulei ZhangZÖHRE KURTİHSAN GÜRSEL

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.